Pages that link to "Q71606712"
Jump to navigation
Jump to search
The following pages link to Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice (Q71606712):
Displaying 50 items.
- The SH4-Unique-SH3-SH2 domains dictate specificity in signaling that differentiate c-Yes from c-Src (Q23915639) (← links)
- Nuclear matrix binding regulates SATB1-mediated transcriptional repression (Q24300704) (← links)
- The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis (Q24313125) (← links)
- RACK1, a Receptor for Activated C Kinase and a Homolog of the β Subunit of G Proteins, Inhibits Activity of Src Tyrosine Kinases and Growth of NIH 3T3 Cells (Q24315691) (← links)
- Adhesion signaling by a novel mitotic substrate of src kinases (Q24863187) (← links)
- The role of Src in solid tumors (Q24616659) (← links)
- Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer (Q24803054) (← links)
- Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer. (Q24803081) (← links)
- Mouse models for studying angiogenesis and lymphangiogenesis in cancer (Q27003898) (← links)
- Apc Mutation Enhances PyMT-Induced Mammary Tumorigenesis (Q27310772) (← links)
- Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage (Q28201770) (← links)
- Sam68 haploinsufficiency delays onset of mammary tumorigenesis and metastasis (Q28235894) (← links)
- 'Srcasm: a novel Src activating and signaling molecule (Q28505622) (← links)
- Targeting Serglycin Prevents Metastasis in Murine Mammary Carcinoma (Q28552442) (← links)
- Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation (Q28678895) (← links)
- c-Src associates with ErbB2 through an interaction between catalytic domains and confers enhanced transforming potential (Q30157161) (← links)
- The Shp-2 tyrosine phosphatase activates the Src tyrosine kinase by a non-enzymatic mechanism (Q30175786) (← links)
- c-Src, receptor tyrosine kinases, and human cancer (Q30303932) (← links)
- Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression (Q30409213) (← links)
- Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers (Q30453944) (← links)
- The comparative pathology of human and mouse mammary glands (Q33603571) (← links)
- A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer (Q33835581) (← links)
- Signal transduction in mammary tumorigenesis: a transgenic perspective (Q33860827) (← links)
- ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss (Q33878879) (← links)
- Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor (Q33888599) (← links)
- Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. (Q33890864) (← links)
- Suppression of tumor growth and metastasis in Mgat5-deficient mice (Q33892088) (← links)
- Natural biology of polyomavirus middle T antigen (Q33948870) (← links)
- The biology of mammary transgenes: five rules (Q33962717) (← links)
- Requirement for Both Shc and Phosphatidylinositol 3′ Kinase Signaling Pathways in Polyomavirus Middle T-Mediated Mammary Tumorigenesis (Q33996549) (← links)
- Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene (Q34012640) (← links)
- Pilot study on the effects of dietary conjugated linoleic acid on tumorigenesis and gene expression in PyMT transgenic mice (Q34094999) (← links)
- beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression (Q34100493) (← links)
- Role of Src expression and activation in human cancer (Q34103650) (← links)
- Over-expression of ST3Gal-I promotes mammary tumorigenesis (Q34107518) (← links)
- Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis (Q34119101) (← links)
- Oncogenes and tumor suppressor genes (Q34149922) (← links)
- Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells (Q34187445) (← links)
- Subcellular localization of total and activated Src kinase in African American and Caucasian breast cancer (Q34211720) (← links)
- Control of mammary tumor differentiation by SKI-606 (bosutinib) (Q34398204) (← links)
- Phosphorylation of the SRC epithelial substrate Trask is tightly regulated in normal epithelia but widespread in many human epithelial cancers (Q34502396) (← links)
- Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. (Q34792468) (← links)
- Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice (Q34813351) (← links)
- Cellular transformation by Simian Virus 40 and Murine Polyoma Virus T antigens (Q34985587) (← links)
- Transforming growth factor-beta regulator SnoN modulates mammary gland branching morphogenesis, postlactational involution, and mammary tumorigenesis (Q34992779) (← links)
- Physical and functional interaction between polyoma virus middle T antigen and insulin and IGF-I receptors is required for oncogene activation and tumour initiation (Q34993028) (← links)
- Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathways. (Q35000261) (← links)
- Lessons in signaling and tumorigenesis from polyomavirus middle T antigen (Q35000523) (← links)
- Pre-clinical applications of transgenic mouse mammary cancer models. (Q35037410) (← links)
- Genetically engineered mice as experimental tools to dissect the critical events in breast cancer (Q35146602) (← links)